UX-810

N/A

Report date: 2025/01/26 16:14:00

Base Information

Drug NameUX-810
Drug Alias NameAAV based microdystrophin gene therapy (Ultragenyx/Solid Biosciences)UX-810
ClassificationBiologics
Mechanisms of ActionDystrophin expression stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUltragenyx Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesSolid Biosciences IncUltragenyx Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A